BPC 157, or Body Protective Compound 157, is a peptide derived from a naturally occurring protein in the human body
Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
Is the injection site important for lipotropic injections
[DOI] [PubMed] [Google Scholar] 9.Delpre G, Stark P, Niv Y
Sorli C, Harashima SI, Tsoukas GM, et al
Reported side effects are generally mild, but long-term safety data in humans is still limited